par Balikdjian, Daniel 
;Balikdjian, M.;Fruhling, Janos
Référence Strahlentherapie, 150, 2, page (127-133)
Publication Publié, 1975
;Balikdjian, M.;Fruhling, Janos Référence Strahlentherapie, 150, 2, page (127-133)
Publication Publié, 1975
Article révisé par les pairs
| Résumé : | The variations of the plasma 59Fe T 1/2 were observed in 20 patients treated by high energy irradiation. They were submitted to a focalized radiotherapy involving a nonnegligible volume of erythropoietic marrow. Among them there were 10 cases of pulmonary cancer, 7 cases of lymphomas, and 3 cases of seminomas. When treatment was limited to an irradiation of the thorax, no significant change of the 59Fe T 1/2 was observed in cases of pulmonary cancer or lymphomas. In case of a supra and infradiaphragmatic irradiation (lymphomas), the 59Fe T 1/2 (initially subnormal) tended to reach normal values after radiotherapy and seems to be independent of the initial value (before irradiation) and of the delivered dose. |
